A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
A phase 2 trial of Ivonescimab, AK117, CAPOX in colorectal cancer, run by Akeso, active and no longer recruiting.
Overview
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer is a phase 2 interventional study registered as NCT05382442 by Akeso, with 254 participants planned, started 2022-06-27 and due to reach its primary completion in 2026-05-15. Interventions recorded: AK112, AK117, Oxaliplatin, Capecitabine, Irinotecan. Conditions listed: Metastatic Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialHSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Ivonescimab, Akeso.
- TrialA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialNeoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Shares CAPOX (capecitabine, oxaliplatin), Akeso, Capecitabine, Colorectal cancer.
- TrialGivastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Capecitabine.
- TrialA Study of Ivonescimab in First-Line ES-SCLC
Shares AK117, Ivonescimab, Akeso.
- TrialA Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Capecitabine, Colorectal cancer.